PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07% Adverse Event: Cystoid macular oedema
PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07% Adverse Event: Cystoid macular oedema is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07%; Product category: Drug; Primary reaction: Cystoid macular oedema.
| Primary drug | PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07% |
|---|---|
| Product category | Drug |
| Primary reaction | Cystoid macular oedema |
| All reactions | Cystoid macular oedema |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | PROLENSA (BROMFENAC OPHTHALMIC SOLUTION) 0.07% |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140313 |
| Report ID | 10006482 |
$299/mo
Try FDATracker →